鸡HMIT基因的克隆与表达分析

doi:10.11843/j.issn.0366-6964.2020.08.005

摘要/Abstract

摘要： 旨在克隆鸡H+/肌醇转运蛋白（H+/myoinositol transporter，HMIT）基因的转录序列，并检测HMIT基因在鸡不同组织中的表达情况，以及外源胰岛素处理对HMIT基因相对表达量的影响。本研究以AA肉鸡为试验动物，采用RT-PCR技术克隆鸡HMIT基因全编码区序列，采用生物信息学技术分析其编码蛋白的生物学特性，利用荧光定量PCR检测HMIT基因在大脑、肝、腹脂、腿肌、心、肾、空肠和回肠等组织中的表达情况，并检测其在肾和大脑中进行胰岛素处理120和240 min后的表达情况。结果表明，以NCBI预测的鸡HMIT（XM_001232939.5）序列为模板设计引物，成功克隆出鸡HMIT基因（1 694 bp，GenBank登录号：MN708211）。克隆的鸡HMIT编码区全长1 380 bp，相比XM_001232939.5预测的编码序列少561 bp，预测编码含有459个氨基酸组成的蛋白。核苷酸和氨基酸序列比对发现，鸡HMIT在物种间高度同源，共线性分析显示，HMIT所在的1号染色体区域在物种间也是高度保守的。HMIT编码的蛋白质是一种不稳定的亲水性蛋白质，其二级结构和三级结构以无规则卷曲和α-螺旋为主。跨膜结构分析显示，鸡HMIT存在8个明显的跨膜结构域。亚细胞定位结果表明，鸡HMIT蛋白分布于质膜（52.3%）、内质网（21.7%）、液泡（17.4%）、线粒体（4.3%）和高尔基体（4.3%）。实时荧光定量PCR检测结果显示，HMIT基因在鸡大脑和肾表达量最高，且显著高于其他组织（P<0.05）。胰岛素处理240 min后，HMIT在肾和大脑中的表达量都显著低于PBS对照组（P<0.05）。本研究克隆获得了鸡HMIT的全编码区，生物信息学分析及组织表达特性研究为深入探索鸡HMIT基因的生理功能和调控机制奠定基础。

关键词: HMIT, 基因克隆, 生物信息学分析, 组织表达, 胰岛素

Abstract: The aim of this study was to clone the transcriptional sequence of chicken H+/myoinositol transporter (HMIT) gene, and to detect its expression in different tissues of chickens, and to explore the effect of exogenous insulin treatment on the relative expression of HMIT gene. In this study, AA broilers were used as experimental animals. The full-length coding region of chicken HMIT gene was cloned by RT-PCR technique, and the biological characteristics of its encoded protein were analyzed by bioinformatics technology. The expressions of HMIT gene in brain, liver, abdominal fat, leg muscle, heart, kidney, jejunum and ileum were detected by fluorescence quantitative PCR. The expressions of HMIT gene in kidney and brain were studied after insulin treatment for 120 and 240 min. The results showed that the chicken HMIT gene (1 694 bp, GenBank accession number: MN708211) was successfully cloned by using the chicken HMIT sequence(XM_001232939.5) predicted by NCBI as a template. The cloned full-length coding region of chicken HMIT was 1 380 bp, which was less than the predicted coding sequence(XM_001232939.5) of 561 bp, which contained a protein of 459 amino acids. Nucleotide and amino acid sequence alignment showed that chicken HMIT was highly homologous among species. The collinearity analysis showed that the region of chromosome 1 where HMIT was located was also highly conserved among species. The protein encoded by HMIT was an unstable hydrophilic protein, its secondary and tertiary structure were mainly composed of random coil and α-helix. Transmembrane structure analysis showed that there were 8 distinct transmembrane domains in chicken HMIT. The results of subcellular localization showed that chicken HMIT protein was distributed in plasma membrane (52.3%), endoplasmic reticulum (21.7%), vacuole (17.4%), mitochondria (4.3%) and Golgi apparatus (4.3%). The results of real-time fluorescence quantitative PCR showed that the expressions of HMIT gene were the highest in chicken brain and kidney, which was significantly higher than those in other tissues(P<0.05). At 240 min after insulin treatment, the expressions of HMIT in kidney and brain were significantly lower than that in PBS control group (P<0.05). In this study, the full-length coding region of chicken HMIT was cloned, the results of bioinformatics and tissue expression characteristics analysis laid a foundation for further exploration of the physiological function and regulatory mechanism of chicken HMIT gene.

Key words: HMIT, gene cloning, bioinformatics analysis, tissue expression, insulin

中图分类号:

S831.2

杜鹏飞, 陈博, 高林歌, 朱瑶, 张向丽, 朱星浩, 陈文, 黄艳群. 鸡HMIT基因的克隆与表达分析[J]. 畜牧兽医学报, 2020, 51(8): 1811-1822.

DU Pengfei, CHEN Bo, GAO Lin'ge, ZHU Yao, ZHANG Xiangli, ZHU Xinghao, CHEN Wen, HUANG Yanqun. Cloning and Expression Analysis of Chicken HMIT Gene[J]. Acta Veterinaria et Zootechnica Sinica, 2020, 51(8): 1811-1822.

参考文献 41

[1]	WANG J Q,YU J C,ZHANG Y Q,et al.Glucose transporter inhibitor-conjugated insulin mitigates hypoglycemia[J].Proc Natl Acad Sci U S A,2019,116(22):10744-10748.
[2]	BYERS M S,HOWARD C,WANG X F.Avian and mammalian facilitative glucose transporters[J].Microarrays 2017,6(2):7.
[3]	MUECKLER M,THORENS B.The SLC2(GLUT) family of membrane transporters[J].Mol Aspects Med,2013,34(2-3):121-138.
[4]	DENG D,YAN N.GLUT,SGLT,and SWEET:structural and mechanistic investigations of the glucose transporters[J].Protein Sci,2016,25(3):546-558.
[5]	YAN N.A glimpse of membrane transport through structures-advances in the structural biology of the GLUT glucose transporters[J].J Mol Biol,2017,429(17):2710-2725.
[6]	THORENS B,MUECKLER M.Glucose transporters in the 21st Century[J].Am J Physiol Endocrinol Metab,2010,298(2):E141-145.
[7]	ULDRY M,STEINER P,ZURICH M G,et al.Regulated exocytosis of an H+/myo-inositol symporter at synapses and growth cones[J].EMBO J,2004,23(3):531-540.
[8]	FARIAS V X,UCHOA P N,AQUINO C P,et al.Expression of myo-inositol cotransporters in the sciatic nerve and dorsal root ganglia in experimental diabetes[J].Braz J Med Biol Res,2019,52(6):e8589.
[9]	FERREIRA R S,PONS J L,LABESSE G.Insights into substrate and inhibitor selectivity among human GLUT transporters through comparative modeling and molecular docking[J].ACS Omega,2019,4(3):4748-4760.
[10]	EDAMATSU M,KONDO Y,ANDO M.Differential localizations of the myo-inositol transporters HMIT and SMIT1 in the cochlear stria vascularis[J].Neurosci Lett,2018,674:88-93.
[11]	ULDRY M,IBBERSON M,HORISBERGER J D,et al.Identification of a mammalian H+-myo-inositol symporter expressed predominantly in the brain[J].EMBO J,2001,20(16):4467-4477.
[12]	ULDRY M,THORENS B.The SLC2 family of facilitated hexose and polyol transporters[J].Pflügers Arch,2004,447(5):480-489.
[13]	CROZE M L,SOULAGE C O.Potential role and therapeutic interests of myo-inositol in metabolic diseases[J].Biochimie, 2013, 95(10):1811-1827.
[14]	DI DANIEL E,KEW J N,MAYCOX P R.Investigation of the H+-myo-inositol transporter (HMIT) as a neuronal regulator of phosphoinositide signalling[J].Biochem Soc Trans,2009,37(5):1139-1143.
[15]	LYU M,ZHOU J,CHEN H,et al.The genetic variants in calcium signaling related genes influence anti-tuberculosis drug induced liver injury:a prospective study[J].Medicine (Baltimore),2019,98(44):e17821.
[16]	DONG J,WEN L,GUO X Y,et al.The increased expression of glucose transporters in human full-term placentas from assisted reproductive technology without changes of mTOR signaling[J].Placenta,2019,86:4-10.
[17]	YANG W J,LIU H L,DUAN B S,et al.Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk[J].Cancer Sci,2019,110(6):2022-2032.
[18]	MERKIN J,RUSSELL C,CHEN P,et al.Evolutionary dynamics of gene and isoform regulation in Mammalian tissues[J].Science, 2012,338(6114):1593-1599.
[19]	刘宗立,陈涛,杨丹丹,等.猪Nrf2基因克隆、生物信息学分析及启动子区转录活性分析[J].畜牧兽医学报, 2019, 50(7):1328-1339.LIU Z L,CHEN T,YANG D D,et al,Molecular cloning,bioinformatics analysis and transcriptional activity of promoter of nuclear factor erythroid 2-related factor (Nrf2) gene in pig[J] Acta Veterinaria et Zootechnica Sinica,2019,50(7):1328-1339.(in Chinese)
[20]	郭晓红,李萌,高鹏飞,等.猪MYNN基因可变剪接体的克隆及表达特性研究[J].畜牧兽医学报,2018,49(3):477-487.GUO X H,LI M,GAO P F,et al,Molecular cloning on alternative splice variants of pig MYNN gene and their expression patterns[J] Acta Veterinaria et Zootechnica Sinica,2018,49(3):477-487.(in Chinese)
[21]	SCHNEIDER S.Inositol transport proteins[J].FEBS Lett,2015,589(10):1049-1058.
[22]	AUGUSTIN R.The protein family of glucose transport facilitators:it's not only about glucose after all[J].IUBMB Life,2010, 62(5):315-333.
[23]	FAGERBERG L,HALLSTRÖM B M,OKSVOLD P,et al.Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics[J].Mol Cell Proteomics,2014,13(2):397-406.
[24]	BARBOSA-MORAIS N L,IRIMIA M,PAN Q,et al.The evolutionary landscape of alternative splicing in vertebrate species[J]. Science, 2012,338(6114):1587-1593.
[25]	INOUE M,HUR J Y,KIHARA T,et al.Human brain proteins showing neuron-specific interactions with γ-secretase[J].FEBS J,2015,282(14):2587-2599.
[26]	KAGE-NAKADAI E,UEHARA T,MITANI S.H+/myo-inositol transporter genes,hmit-1.1 and hmit-1.2,have roles in the osmoprotective response in Caenorhabditis elegans[J].Biochem Biophys Res Commun,2011,410(3):471-477.
[27]	MACFARLANE P M,DI FIORE J M.Myo-inositol effects on the developing respiratory neural control system[J].Adv Exp Med Biol, 2018, 1071:159-166.
[28]	SUN T H,HEIMARK D B,NGUYGEN T,et al.Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls[J].Biochem Biophys Res Commun,2002,293(3):1092-1098.
[29]	CROZE M L,VELLA R E,PILLON N J,et al.Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice[J].J Nutr Biochem,2013,24(2):457-466.
[30]	VILLALBA H,SHAH K,ALBEKAIRI T H,et al.Potential role of myo-inositol to improve ischemic stroke outcome in diabetic mouse[J].Brain Res,2018,1699:166-176.
[31]	IANCU C V,ZAMOON J,WOO S B,et al.Crystal structure of a glucose/H+ symporter and its mechanism of action[J].Proc Natl Acad Sci U S A,2013,110(44):17862-17867.
[32]	BAZZONE A,ZABADNE A J,SALISOWSKI A,et al.A loose relationship:incomplete H+/sugar coupling in the MFS sugar transporter GlcP[J]. Biophys J,2017,113(12):2736-2749.
[33]	YAN N.Structural biology of the major facilitator superfamily transporters[J].Annu Rev Biophys,2015,44(1):257-283.
[34]	DENG D,XU C,SUN P C,et al.Crystal structure of the human glucose transporter GLUT1[J].Nature,2014,510(7503):121-125.
[35]	YAN N.Structural advances for the major facilitator superfamily (MFS) transporters[J].Trends Biochem Sci,2013,38(3):151-159.
[36]	WILLSON B J,DALZELL L,CHAPMAN L N M,et al.Enhanced functionalisation of major facilitator superfamily transporters via fusion of C-terminal protein domains is both extensive and varied in bacteria[J].Microbiology,2019,165(4):419-424.
[37]	TERANISHI Y,INOUE M,YAMAMOTO N G,et al.Proton myo-nositol cotransporter is a novel γ-ecretase associated protein that regulates Aβ production without affecting Notch cleavage[J].FEBS J,2015,282(17):3438-3451.
[38]	VAWTER M P,HAMZEH A R,MURADYAN E,et al.Association of Myoinositol transporters with schizophrenia and bipolar disorder:evidence from human and animal studies[J].Mol Neuropsychiatry,2019,5(4):200-211.
[39]	LEE D G,LEE J H,CHOI B K,et al.H+-myo-inositol transporter SLC2A13 as a potential marker for cancer stem cells in an oral squamous cell carcinoma[J].Curr Cancer Drug Targets,2011,11(8):966-975.
[40]	GAO Y F,ZHANG M N,WANG T X,et al.Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K/Akt signaling pathway[J].Mol Cell Endocrinol,2016,433:26-34.
[41]	LAI B B,LAI Y L,ZHANG Y L,et al.The solute carrier family 2 genes are potential prognostic biomarkers in acute myeloid leukemia[J].Technol Cancer Res Treat,2020,19.